According to the CRESSC goal of Research Promotion, the Center instituted many scientific collaborations, both National and International.

Genetic studies for the familiar forms and clinical trials have been activated with the following purposes: to evaluate Chiari Syndrome/Siringomielia prevalence; to identify regional diagnostic-therapeutic protocols; to promote multidisciplinary model, optimizing the use of resources and improving the users’ health, even in terms of life quality (approved by Ethics Committee, Protocol n.7837 of 01/02/2010, AOU Città della Salute e della Scienza di Torino).

On a National level, we have to mention collaborations with the Syringomyelia and Chiari Syndrome Interregional Consortium and the Piemonte and Valle d’Aosta Interregional Network for Rare Diseases,  with the Department of Medical Sciences, Department of Molecular Biotechnologies and Health Science, University of Torino,  with the Department of Health Sciences, University of Piemonte Orientale,  with the National Center for Rare Diseases of the National Institute of Health, and with patient Associations.

On an International level, among the main collaborations: “Centre de Référence de la Syringomyélie” of Paris, France (Pr. Fabrice Parker); University Hospital Birmingham, UK (Pr. Graham Flint); The Chiari Institute of New York, US (Pr. Harold Rekate); Chiari Neurosurgical Center of New York, US (Dr. Paolo Bolognese); Duke University of Durham , North Carolina, US (Pr. Allison Ashley-Koch, Prof Simon Gregory). Projects on epidemiological and genetic aspects in Chiari Malformation, with or without Syringomyelia, hereditary disorders of connective tissue (HDCT) and tethered cord syndrome (TCS) have been launched (amendment to Protocol n. 7837 of 01/02/2010 with integration of the participating centers, approved by Ethics Committee, Protocol n.52554 of 20/5/2015, AOU Città della Salute e della Scienza di Torino).